BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32266734)

  • 1. Emerging carrier-free nanosystems based on molecular self-assembly of pure drugs for cancer therapy.
    Zhang X; Li N; Zhang S; Sun B; Chen Q; He Z; Luo C; Sun J
    Med Res Rev; 2020 Sep; 40(5):1754-1775. PubMed ID: 32266734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Paclitaxel-based Self-Delivery Nanomedicine for Cancer Therapy.
    Zhou M; Han S; Aras O; An F
    Curr Med Chem; 2021; 28(31):6358-6374. PubMed ID: 33176629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery.
    Li G; Sun B; Li Y; Luo C; He Z; Sun J
    Small; 2021 Dec; 17(52):e2101460. PubMed ID: 34342126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy.
    Fu S; Li G; Zang W; Zhou X; Shi K; Zhai Y
    Acta Pharm Sin B; 2022 Jan; 12(1):92-106. PubMed ID: 35127374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimeric prodrug-based nanomedicines for cancer therapy.
    Li S; Shan X; Wang Y; Chen Q; Sun J; He Z; Sun B; Luo C
    J Control Release; 2020 Oct; 326():510-522. PubMed ID: 32721523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Cargo-Free Nanomedicine for Cancer Therapy.
    Wang Y; Yang P; Zhao X; Gao D; Sun N; Tian Z; Ma T; Yang Z
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery.
    Kyu Shim M; Yang S; Sun IC; Kim K
    Adv Drug Deliv Rev; 2022 Apr; 183():114177. PubMed ID: 35245568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine-Cum-Carrier by Co-Assembly of Natural Small Products for Synergistic Enhanced Antitumor with Tissues Protective Actions.
    Wang J; Zhao H; Qiao W; Cheng J; Han Y; Yang X
    ACS Appl Mater Interfaces; 2020 Sep; 12(38):42537-42550. PubMed ID: 32852938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier-Free Nanomedicine for Cancer Immunotherapy.
    Fu Y; Bian X; Li P; Huang Y; Li C
    J Biomed Nanotechnol; 2022 Apr; 18(4):939-956. PubMed ID: 35854464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier-free nanoplatforms from natural plants for enhanced bioactivity.
    Li Z; Xu X; Wang Y; Kong L; Han C
    J Adv Res; 2023 Aug; 50():159-176. PubMed ID: 36208834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in self-assembled nanotechnology in tumor therapy.
    Kuang Y; Li Z; Chen H; Wang X; Wen Y; Chen J
    Colloids Surf B Biointerfaces; 2024 May; 237():113838. PubMed ID: 38484445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative self-assembly of pure drug cocktails as injectable nanomedicines for synergistic drug delivery and cancer therapy.
    Chen X; Xie B; Huang L; Wan J; Wang Y; Shi X; Qiao Y; Song H; Wang H
    Theranostics; 2021; 11(12):5713-5727. PubMed ID: 33897877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Assembled Nanomedicines for Anticancer and Antibacterial Applications.
    Zhou L; Qiu T; Lv F; Liu L; Ying J; Wang S
    Adv Healthc Mater; 2018 Oct; 7(20):e1800670. PubMed ID: 30080319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine.
    Luo C; Sun J; Sun B; Liu D; Miao L; Goodwin TJ; Huang L; He Z
    Small; 2016 Dec; 12(46):6353-6362. PubMed ID: 27689847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Assembled Oxaliplatin(IV) Prodrug-Porphyrin Conjugate for Combinational Photodynamic Therapy and Chemotherapy.
    Lim WQ; Yang G; Phua SZF; Chen H; Zhao Y
    ACS Appl Mater Interfaces; 2019 May; 11(18):16391-16401. PubMed ID: 31002492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile Engineering of Indomethacin-Induced Paclitaxel Nanocrystal Aggregates as Carrier-Free Nanomedicine with Improved Synergetic Antitumor Activity.
    Zhang C; Long L; Xiong Y; Wang C; Peng C; Yuan Y; Liu Z; Lin Y; Jia Y; Zhou X; Li X
    ACS Appl Mater Interfaces; 2019 Mar; 11(10):9872-9883. PubMed ID: 30767506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.
    Shen S; Liu M; Li T; Lin S; Mo R
    Biomater Sci; 2017 Jul; 5(8):1367-1381. PubMed ID: 28664207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances on small-molecule nanomedicines for cancer treatment.
    Xue X; Lindstrom A; Qu H; Li Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 May; 12(3):e1607. PubMed ID: 31840421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Assembly of a Pure Photosensitizer as a Versatile Theragnostic Nanoplatform for Imaging-Guided Antitumor Photothermal Therapy.
    Zhang X; Sun B; Zuo S; Chen Q; Gao Y; Zhao H; Sun M; Chen P; Yu H; Zhang W; Wang K; Zhang R; Kan Q; Zhang H; He Z; Luo C; Sun J
    ACS Appl Mater Interfaces; 2018 Sep; 10(36):30155-30162. PubMed ID: 30125081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy.
    Yang MY; Zhao RR; Fang YF; Jiang JL; Yuan XT; Shao JW
    Int J Pharm; 2019 Oct; 570():118663. PubMed ID: 31493497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.